| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 14th, 2009 | 30 | Yes |
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1415560-69-8 , 877399-52-5 , 877399-52-5, 877399-53-6 (acetate) , 877400-66-3 , [877399-52-5] , [877400-66-3]
(R)-crizotinib; PF 2341066; PF-2341066
2-Pyridinamine, 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[
3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine
877399-52-5; Crizotinib (JAN/USAN/INN); D09731; Xalkori (TN)
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.01 | 9.09 | -96.36 | 5 | 6 | 2 | 84 | 452.361 | 5 | ↓ |
| Mid Mid (pH 6-8) | 4.01 | 8.61 | -52.37 | 4 | 6 | 1 | 83 | 451.353 | 5 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 6.11e-03 g/l | DrugBank-experimental |
| Purity | 95% | Matrix Scientific |
| UniProt Database Links | ALK_HUMAN; ALK_MOUSE | ChEBI |
| Target | c-Met, ALK | Selleck Chemicals |
| Warnings | IRRITANT | Matrix Scientific |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1159 | 0.28 | Binding ≤ 10μM |
| ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.29 | Binding ≤ 10μM |
| INSR-1-E | Insulin Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 650 | 0.29 | Binding ≤ 10μM |
| LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2741 | 0.26 | Binding ≤ 10μM |
| MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.38 | Binding ≤ 10μM |
| MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 19 | 0.36 | Binding ≤ 10μM |
| NTRK1-1-E | Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 580 | 0.29 | Binding ≤ 10μM |
| NTRK2-1-E | Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 399 | 0.30 | Binding ≤ 10μM |
| RON-1-E | Macrophage-stimulating Protein Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
| TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 448 | 0.30 | Binding ≤ 10μM |
| UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 294 | 0.30 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 1 | 0.42 | Binding ≤ 1μM |
| MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 18.3 | 0.36 | Binding ≤ 1μM |
| INSR_HUMAN | P06213 | Insulin Receptor, Human | 102 | 0.33 | Binding ≤ 1μM |
| RON_MOUSE | Q62190 | Macrophage-stimulating Protein Receptor, Mouse | 80 | 0.33 | Binding ≤ 1μM |
| RON_HUMAN | Q04912 | Macrophage-stimulating Protein Receptor, Human | 300 | 0.30 | Binding ≤ 1μM |
| NTRK1_HUMAN | P04629 | Nerve Growth Factor Receptor Trk-A, Human | 1 | 0.42 | Binding ≤ 1μM |
| NTRK2_HUMAN | Q16620 | Neurotrophic Tyrosine Kinase Receptor Type 2, Human | 2 | 0.41 | Binding ≤ 1μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 24 | 0.36 | Binding ≤ 1μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 1 | 0.42 | Binding ≤ 1μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 1 | 0.42 | Binding ≤ 1μM |
| TIE2_MOUSE | Q02858 | Tyrosine-protein Kinase TIE-2, Mouse | 448 | 0.30 | Binding ≤ 1μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 448 | 0.30 | Binding ≤ 1μM |
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 1 | 0.42 | Binding ≤ 10μM |
| MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 18.3 | 0.36 | Binding ≤ 10μM |
| INSR_HUMAN | P06213 | Insulin Receptor, Human | 102 | 0.33 | Binding ≤ 10μM |
| RON_MOUSE | Q62190 | Macrophage-stimulating Protein Receptor, Mouse | 80 | 0.33 | Binding ≤ 10μM |
| RON_HUMAN | Q04912 | Macrophage-stimulating Protein Receptor, Human | 300 | 0.30 | Binding ≤ 10μM |
| NTRK1_HUMAN | P04629 | Nerve Growth Factor Receptor Trk-A, Human | 1 | 0.42 | Binding ≤ 10μM |
| NTRK2_HUMAN | Q16620 | Neurotrophic Tyrosine Kinase Receptor Type 2, Human | 2 | 0.41 | Binding ≤ 10μM |
| ABL1_MOUSE | P00520 | Tyrosine-protein Kinase ABL, Mouse | 1159 | 0.28 | Binding ≤ 10μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1159 | 0.28 | Binding ≤ 10μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 1 | 0.42 | Binding ≤ 10μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 1 | 0.42 | Binding ≤ 10μM |
| TIE2_MOUSE | Q02858 | Tyrosine-protein Kinase TIE-2, Mouse | 448 | 0.30 | Binding ≤ 10μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 448 | 0.30 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| ARMS-mediated activation | |
| CD28 co-stimulation | |
| CD28 dependent PI3K/Akt signaling | |
| CD28 dependent Vav1 pathway | |
| CDO in myogenesis | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CTLA4 inhibitory signaling | |
| DAP12 signaling | |
| Downstream TCR signaling | |
| Factors involved in megakaryocyte development and platelet production | |
| Frs2-mediated activation | |
| Generation of second messenger molecules | |
| GPVI-mediated activation cascade | |
| Insulin receptor recycling | |
| Interleukin-2 signaling | |
| IRS activation | |
| Nef and signal transduction | |
| Nef Mediated CD4 Down-regulation | |
| NGF-independant TRKA activation | |
| PD-1 signaling | |
| PECAM1 interactions | |
| Phosphorylation of CD3 and TCR zeta chains | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| PLC-gamma1 signalling | |
| Regulation of actin dynamics for phagocytic cup formation | |
| Regulation of KIT signaling | |
| Retrograde neurotrophin signalling | |
| Role of Abl in Robo-Slit signaling | |
| Sema4D mediated inhibition of cell attachment and migration | |
| SHC activation | |
| Signal attenuation | |
| Signaling by Insulin receptor | |
| Signaling by SCF-KIT | |
| Signalling to p38 via RIT and RIN | |
| Signalling to RAS | |
| Signalling to STAT3 | |
| Tie2 Signaling | |
| Translocation of ZAP-70 to Immunological synapse | |
| TRKA activation by NGF | |
| VEGFA-VEGFR2 Pathway |